טוען...

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

INTRODUCTION: The long-term goal of chronic hepatitis B (CHB) treatment is improvement of liver disease and prevention of cirrhosis. The aim of this study was to assess whether prolonged telbivudine treatment improves liver inflammation and fibrosis. The primary objective was to evaluate the proport...

תיאור מלא

שמור ב:

מידע ביבליוגרפי
הוצא לאור ב:	Adv Ther
Main Authors:	Hou, Jin-Lin, Xu, Daozheng, Shi, Guangfeng, Wan, Mobin, Goodman, Zachary, Tan, Deming, Xie, Qing, Chen, Chengwei, Wei, Lai, Niu, Junqi, Wang, Qinhuan, Ren, Hong, Wang, Yuming, Jia, Jidong, Bao, Weibin, Dong, Yuhong, Trylesinski, Aldo, Naoumov, Nikolai V.
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Springer Healthcare 2015
נושאים:	Original Research
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4572721/ https://ncbi.nlm.nih.gov/pubmed/26329749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-015-0232-2
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B

פריטים דומים